Senni, M., Jering, K., Claggett, B., Granger, C., Koeber, L., Landmesser, U., … Braunwald, E. (2023). Impact of lower systolic blood pressure on efficacy and safety of sacubitri/valsartan compared to ramipril in patients with acute myocardial infarction: Insights from PARADISE-MI trial. In EUROPEAN JOURNAL OF HEART FAILURE (Vol. 25, pp. 330–331).

Senni, M., K. Jering, B. Claggett, C. Granger, L. Koeber, U. Landmesser, E. F. Lewis, et al. “Impact of lower systolic blood pressure on efficacy and safety of sacubitri/valsartan compared to ramipril in patients with acute myocardial infarction: Insights from PARADISE-MI trial.” In EUROPEAN JOURNAL OF HEART FAILURE, 25:330–31, 2023.

Senni M, Jering K, Claggett B, Granger C, Koeber L, Landmesser U, et al. Impact of lower systolic blood pressure on efficacy and safety of sacubitri/valsartan compared to ramipril in patients with acute myocardial infarction: Insights from PARADISE-MI trial. In: EUROPEAN JOURNAL OF HEART FAILURE. 2023. p. 330–1.

Senni, M., et al. “Impact of lower systolic blood pressure on efficacy and safety of sacubitri/valsartan compared to ramipril in patients with acute myocardial infarction: Insights from PARADISE-MI trial.” EUROPEAN JOURNAL OF HEART FAILURE, vol. 25, 2023, pp. 330–31.

Senni M, Jering K, Claggett B, Granger C, Koeber L, Landmesser U, Lewis EF, Mann D, Mcmurray JJV, Merkely B, Rouleau JL, Solomon SD, Steg PG, Van der Meer P, Braunwald E. Impact of lower systolic blood pressure on efficacy and safety of sacubitri/valsartan compared to ramipril in patients with acute myocardial infarction: Insights from PARADISE-MI trial. EUROPEAN JOURNAL OF HEART FAILURE. 2023. p. 330–331.